Currently, Allon has two products in clinical development available for potential partnerships and out-licensing opportunities. We will consider opportunities where there is a complementary science or expertise consistent with the company’s core strength in neurodegenerative conditions, and the potential for a good strategic fit.

Allon has collaborations today with the National Institute of Aging, the Alzheimer's Disease Cooperative Study, the Institute for the Study of Aging and the Tel Aviv University.